Publications by authors named "An Vandebosch"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,129,283

Total Likes

22,778

Extended Reach

2,238,248

Social Features

286
S
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn, Paul A Goepfert, Carla Truyers, Hein Fennema, Bart Spiessens

June 2021

Videos about Article: user user user 1

4 10 282 15 214 2

View All Article and Social Media Activity
N
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Lindsay N Carpp, Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, An Vandebosch

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Craig A Magaret, Li Li, Allan C deCamp, Morgane Rolland, Michal Juraska, An Vandebosch

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
Christine B Turley, LaKesha Tables, Trevon Fuller, Lisa J Sanders, Hyman Scott, An Vandebosch

Vaccine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Craig Magaret, Li Li, Allan deCamp, Morgane Rolland, Michal Juraska, An Vandebosch

Res Sq· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Karin Hardt, An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers

Lancet Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.
Youyi Fong, Adrian B McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch

Nat Microbiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study.
Jerald Sadoff, Els De Paepe, John DeVincenzo, Efi Gymnopoulou, Joris Menten, An Vandebosch

J Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.
Youyi Fong, Adrian B McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch

medRxiv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomized clinical trial.
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt

Biom J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
Dean Follmann, Jonathan Fintzi, Michael P Fay, Holly E Janes, Lindsey R Baden, An Vandebosch

Ann Intern Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
An Vandebosch, Jerald Sadoff, Macaya Douoguih

N Engl J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel estimand to adjust for rescue treatment in randomized clinical trials.
Hege Michiels, Cristina Sotto, An Vandebosch, Stijn Vansteelandt

Stat Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
Devan V Mehrotra, Holly E Janes, Thomas R Fleming, Paula W Annunziato, Kathleen M Neuzil, An Vandebosch

Ann Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
Ramon Roozendaal, Jenny Hendriks, Thierry van Effelterre, Bart Spiessens, Liesbeth Dekking, An Vandebosch

NPJ Vaccines· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials.
Dean Follmann, Jonathan Fintzi, Michael P Fay, Holly E Janes, Lindsey Baden, An Vandebosch

medRxiv· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving interim decisions in randomized trials by exploiting information on short-term endpoints and prognostic baseline covariates.
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt

Pharm Stat· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating futility of a binary clinical endpoint using early read-outs.
Kelly Van Lancker, An Vandebosch, Stijn Vansteelandt, Filip De Ridder

Stat Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.
Paul Meyvisch, Chrispin Kambili, Koen Andries, Nacer Lounis, Myriam Theeuwes, An Vandebosch

PLoS One· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
Damayanthi Devineni, Prasarn Manitpisitkul, Joseph Murphy, Donna Skee, Ewa Wajs, An Vandebosch

Clin Pharmacol Drug Dev· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845.
Leen Vijgen, Kim Thys, An Vandebosch, Pieter Van Remoortere, René Verloes

Virol J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.
Stefan Bourgeois, Hans Van Vlierberghe, Christophe Moreno, Hans Orlent, Frederik Nevens, An Vandebosch

BMC Gastroenterol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges.
An Vandebosch, Robin Mogg, Nele Goeyvaerts, Carla Truyers, Brian Greenwood

Clin Trials· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia.
Stefaan Rossenu, Adriaan Cleton, David Hough, Herta Crauwels, An Vandebosch

Clin Pharmacol Drug Dev· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis